Stock listing
NASDAQ:OVID Ovid Therapeutics Inc. Stock
Home listing (NASDAQ) of Ovid Therapeutics Inc.
Follow Ovid Therapeutics Inc. into a list and get an email when it puts out news.
Share price · NASDAQ:OVID
$2.39 USD -0.15 (-5.9%)
Close on Nov 2, 2026
- Day range
- $2.37 – $2.60 USDNov 2, 2026
- Volume
- 2.34M sharesNov 2, 2026
- Market cap
- $466.8M USDAt the close on Nov 2, 2026 · price × 195.3M shares outstanding
- 52-week range
- $1.18 – $3.11 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $4.39M USDMedian day 1.41M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:OVID · Home | $2.39 USD | -0.15 (-5.9%) | 2,336,559 | $2.55 | $2.60 | $2.37 | $2.54 | Close on Nov 2, 2026 |
| Frankfurt:1OT | €2.24 EUR | +0.24 (+12.0%) | — | €2.24 | €2.24 | €2.24 | €2.00 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:OVID · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.39 | -0.15 | -5.9% | $2.55 | $2.60 | $2.37 | 2,336,559 | |
| $2.54 | -0.02 | -0.8% | $2.44 | $2.70 | $2.44 | 3,145,510 | |
| $2.56 | +0.11 | +4.5% | $2.45 | $2.58 | $2.405 | 2,041,451 | |
| $2.45 | +0.19 | +8.4% | $2.26 | $2.495 | $2.205 | 2,052,841 | |
| $2.26 | +0.105 | +4.9% | $2.18 | $2.28 | $2.10 | 1,691,775 | |
| $2.155 | -0.005 | -0.2% | $2.19 | $2.22 | $2.121 | 843,864 | |
| $2.16 | -0.21 | -8.9% | $2.31 | $2.32 | $2.12 | 2,017,300 | |
| $2.37 | -0.10 | -4.0% | $2.45 | $2.50 | $2.34 | 1,177,600 | |
| $2.47 | +0.11 | +4.7% | $2.37 | $2.65 | $2.345 | 5,003,000 | |
| $2.36 | +0.19 | +8.8% | $2.19 | $2.46 | $2.175 | 3,668,300 | |
| $2.17 | +0.02 | +0.9% | $2.18 | $2.225 | $2.14 | 1,641,100 | |
| $2.15 | -0.11 | -4.9% | $2.26 | $2.30 | $2.11 | 1,325,400 | |
| $2.26 | +0.07 | +3.2% | $2.21 | $2.31 | $2.19 | 1,333,200 | |
| $2.19 | 0.00 | 0.0% | $2.18 | $2.255 | $2.09 | 1,642,400 | |
| $2.19 | -0.22 | -9.1% | $2.41 | $2.415 | $2.18 | 1,642,700 | |
| $2.41 | -0.05 | -2.0% | $2.45 | $2.493 | $2.394 | 876,000 | |
| $2.46 | +0.12 | +5.1% | $2.37 | $2.475 | $2.33 | 1,406,700 | |
| $2.34 | -0.02 | -0.8% | $2.32 | $2.36 | $2.29 | 1,646,800 | |
| $2.36 | -0.01 | -0.4% | $2.36 | $2.46 | $2.34 | 1,003,700 | |
| $2.37 | +0.03 | +1.3% | $2.42 | $2.44 | $2.27 | 1,735,000 | |
| $2.34 | -0.04 | -1.7% | $2.38 | $2.47 | $2.29 | 1,192,400 | |
| $2.38 | -0.05 | -2.1% | $2.47 | $2.48 | $2.33 | 2,173,400 | |
| $2.43 | -0.06 | -2.4% | $2.49 | $2.53 | $2.42 | 1,349,500 | |
| $2.49 | -0.05 | -2.0% | $2.54 | $2.605 | $2.48 | 1,442,400 | |
| $2.54 | +0.08 | +3.3% | $2.47 | $2.54 | $2.42 | 1,163,600 | |
| $2.46 | +0.06 | +2.5% | $2.40 | $2.49 | $2.35 | 1,192,400 | |
| $2.40 | -0.095 | -3.8% | $2.49 | $2.51 | $2.40 | 1,364,800 | |
| $2.495 | -0.075 | -2.9% | $2.54 | $2.54 | $2.405 | 1,528,500 | |
| $2.57 | -0.19 | -6.9% | $2.75 | $2.75 | $2.44 | 2,635,300 | |
| $2.76 | +0.05 | +1.8% | $2.76 | $2.845 | $2.714 | 3,742,800 | |
| $2.71 | +0.02 | +0.7% | $2.73 | $2.76 | $2.65 | 1,183,000 | |
| $2.69 | -0.01 | -0.4% | $2.68 | $2.73 | $2.63 | 5,899,300 | |
| $2.70 | +0.02 | +0.7% | $2.73 | $2.77 | $2.66 | 1,985,800 | |
| $2.68 | -0.03 | -1.1% | $2.72 | $2.765 | $2.65 | 1,428,000 | |
| $2.71 | -0.03 | -1.1% | $2.73 | $2.745 | $2.63 | 988,500 | |
| $2.74 | +0.05 | +1.9% | $2.755 | $2.795 | $2.69 | 1,199,200 | |
| $2.69 | +0.06 | +2.3% | $2.73 | $2.73 | $2.64 | 1,147,400 | |
| $2.63 | -0.07 | -2.6% | $2.68 | $2.70 | $2.61 | 1,403,300 | |
| $2.70 | -0.05 | -1.8% | $2.74 | $2.781 | $2.685 | 1,263,800 | |
| $2.75 | -0.05 | -1.8% | $2.75 | $2.81 | $2.73 | 1,150,400 | |
| $2.80 | +0.02 | +0.7% | $2.74 | $2.825 | $2.71 | 1,066,000 | |
| $2.78 | +0.07 | +2.6% | $2.80 | $2.83 | $2.73 | 1,361,900 | |
| $2.71 | -0.05 | -1.8% | $2.78 | $2.87 | $2.68 | 1,555,900 | |
| $2.76 | +0.09 | +3.4% | $2.65 | $2.78 | $2.64 | 1,294,900 | |
| $2.67 | -0.13 | -4.6% | $2.78 | $2.805 | $2.65 | 1,392,600 | |
| $2.80 | -0.13 | -4.4% | $2.87 | $2.93 | $2.76 | 1,673,700 | |
| $2.93 | +0.05 | +1.7% | $2.85 | $2.95 | $2.83 | 1,722,000 | |
| $2.88 | -0.03 | -1.0% | $2.905 | $2.93 | $2.845 | 1,143,200 | |
| $2.91 | +0.09 | +3.2% | $2.85 | $2.94 | $2.815 | 1,449,582 | |
| $2.82 | +0.02 | +0.7% | $2.79 | $2.86 | $2.67 | 1,230,370 | |
| $2.80 | +0.06 | +2.2% | $2.76 | $2.83 | $2.71 | 1,331,900 | |
| $2.74 | -0.19 | -6.5% | $2.88 | $2.93 | $2.72 | 1,146,500 | |
| $2.93 | +0.09 | +3.2% | $2.90 | $2.95 | $2.84 | 2,875,500 | |
| $2.84 | -0.05 | -1.7% | $2.87 | $2.905 | $2.795 | 1,935,200 | |
| $2.89 | +0.06 | +2.1% | $2.83 | $2.92 | $2.80 | 1,747,800 | |
| $2.83 | +0.03 | +1.1% | $2.80 | $2.87 | $2.745 | 1,240,900 | |
| $2.80 | +0.18 | +6.9% | $2.65 | $2.875 | $2.62 | 2,242,800 | |
| $2.62 | +0.04 | +1.6% | $2.44 | $2.645 | $2.43 | 931,400 | |
| $2.58 | -0.04 | -1.5% | $2.62 | $2.65 | $2.525 | 903,202 | |
| $2.62 | -0.01 | -0.4% | $2.59 | $2.62 | $2.53 | 1,252,320 | |
| $2.63 | -0.02 | -0.8% | $2.69 | $2.69 | $2.60 | 919,700 | |
| $2.65 | +0.03 | +1.1% | $2.62 | $2.685 | $2.585 | 1,294,400 | |
| $2.62 | +0.08 | +3.1% | $2.52 | $2.68 | $2.49 | 2,253,500 | |
| $2.54 | +0.21 | +9.0% | $2.33 | $2.555 | $2.33 | 1,666,200 | |
| $2.33 | +0.11 | +5.0% | $2.222 | $2.36 | $2.222 | 1,677,500 |
- Ticker
- NASDAQ:OVID
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Sep 3, 2026
Ovid Therapeutics to Participate in Upcoming Investor Conferences
Latest earnings call · Mar 18, 2026
Ovid Therapeutics (NASDAQ:OVID) Q4 2025 Earnings Call
Replay and transcript
Latest deck · Mar 18, 2026
Q4 2025 Earnings Presentation
Earnings · 41 slides
Calls
Replays
Ovid Therapeutics (NASDAQ:OVID) Q4 2025 Earnings Call
Wed, Mar 18, 2026 · 8:30 AM ET
Watch Transcript
Latest news
Ovid Therapeutics to Participate in Upcoming Investor Conferences
Sep 3, 2026
Closed $2.78 (+2.6%) on Sep 3, 2026
Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results
Aug 13, 2026
Closed $2.80 (+6.9%) on Aug 13, 2026
Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development
Jul 8, 2026
Closed $2.73 (-1.1%) on Jul 8, 2026
Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
Jun 3, 2026
Closed $2.39 (-0.4%) on Jun 3, 2026
Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results
May 12, 2026
Closed $2.87 (+2.9%) on May 12, 2026
Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14
Apr 8, 2026
Closed $2.60 (+1.6%) on Apr 8, 2026
Ovid Therapeutics Announces Pricing of $60 Million Private Placement
Mar 18, 2026
Closed $2.30 (+14.4%) on Mar 18, 2026
Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results
Mar 18, 2026
Closed $2.30 (+14.4%) on Mar 18, 2026
Decks
Q4 2025 Earnings Presentation
Earnings · 41 slides · Mar 18, 2026
Investor Presentation (June 2025)
Investor deck · 30 slides · June 2025
Investor Day (November 2024)
Investor day · 87 slides · Nov 13, 2024
Investor Day (October 2023)
Investor day · 106 slides · Oct 2, 2023
Ovid Therapeutics Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 126 in all · newest Sep 3, 2026 · oldest 2019
- Calls
- 1 call with a replay · 1 with a transcript · latest Mar 18, 2026
- Decks
- 28 decks · latest Mar 18, 2026
Where Ovid Therapeutics Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:OVID · Home listing · This page | NASDAQ | United States | USD |
| gettex:1OT | gettex | Germany | EUR |
| LS Exchange:A2DQ8S | LS Exchange | Germany | EUR |
| Lang & Schwarz:A2DQ8S | Lang & Schwarz | Germany | EUR |
| BOATS:OVID | BOATS | United States | USD |
| Tradegate:1OT | Tradegate | Germany | EUR |
| Dusseldorf:1OT | Dusseldorf | Germany | EUR |
| Frankfurt:1OT | Frankfurt | Germany | EUR |
| Hamburg:1OT | Hamburg | Germany | EUR |
| Munich:1OT | Munich | Germany | EUR |
| Stuttgart:1OT | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Ovid Therapeutics Inc.